SOD1 and depressive symptom measurement: By analyzing a cohort of 224 patients, we identified key biomarkers, including sRAGE, MCP, hsCRP, antioxidant capacity, and SOD, that can be coupled with psychiatric assessments to assess the risk of depression and delirium pre- and post-CABG.